95 related articles for article (PubMed ID: 1412862)
1. Sri Lankan experience with three immunosuppressive protocols in living related donor kidney transplantation.
Sheriffdeen AH; de Abrew K; Jayasekera G; Nanayakkara S; de Mel CP; Jayasinghe S; Fernando H; Rajakanthan K; Weerasinghe A; Kuruppruarchchi L
Transplant Proc; 1992 Oct; 24(5):1818. PubMed ID: 1412862
[No Abstract] [Full Text] [Related]
2. Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression.
Francis DM; Walker RG; Millar RJ; Becker G
Transplant Proc; 1992 Oct; 24(5):1887-8. PubMed ID: 1412899
[No Abstract] [Full Text] [Related]
3. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
[No Abstract] [Full Text] [Related]
4. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
[No Abstract] [Full Text] [Related]
5. Plasma exchange vs cyclosporine retrieval therapy in steroid-resistant acute rejection of renal allografts.
Dikshit MP; Acharya VN; Trivedi HS; Almeida AF
Transplant Proc; 1992 Oct; 24(5):1724. PubMed ID: 1412811
[No Abstract] [Full Text] [Related]
6. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
7. Live donor renal transplantation with low-dose triple immunosuppression.
Francis DM; Millar RJ; Walker RG; Nicholls K; Powell H; Jones C; Kockelbergh R; Becker G
Transplant Proc; 1992 Oct; 24(5):2243. PubMed ID: 1413041
[No Abstract] [Full Text] [Related]
8. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239
[No Abstract] [Full Text] [Related]
9. Living-related kidney transplantation using low-dose triple immunosuppression.
Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
[No Abstract] [Full Text] [Related]
10. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
11. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
[No Abstract] [Full Text] [Related]
13. Cyclosporine immunosuppression in non-heart-beating cadaver donors.
Asano H; Uchida K; Tominaga Y; Haba T; Sato K; Numano M; Orihara A; Yokoyama I; Takagi H
Transplant Proc; 1992 Oct; 24(5):2042-3. PubMed ID: 1412965
[No Abstract] [Full Text] [Related]
14. Donor-specific transfusion in living-related renal transplants.
Basri N; Nezamuddin N; Aman H; Banqash H; Sharwani N
Transplant Proc; 1992 Oct; 24(5):1746. PubMed ID: 1412822
[No Abstract] [Full Text] [Related]
15. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF
Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
[No Abstract] [Full Text] [Related]
16. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
[No Abstract] [Full Text] [Related]
17. Short-term cyclosporine conversion in living related donor renal transplantation--preliminary observations.
Rahman M; Wahab MA; Rashid HU; Kibria SG; Rahman S; Khan MF
Transplant Proc; 1992 Oct; 24(5):1696-7. PubMed ID: 1412801
[No Abstract] [Full Text] [Related]
18. Optimal clinical regimens for living related liver transplantation.
Malagó M; Rogiers X; Wadström J; Burdelski M; Broelsch CE
Transplant Proc; 1994 Oct; 26(5):2665-8. PubMed ID: 7940834
[No Abstract] [Full Text] [Related]
19. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911
[TBL] [Abstract][Full Text] [Related]
20. Triple-drug regimen for first kidney transplants in developing countries.
Erken U; Erken E; Tansuğ Z; Türkyilmaz R
Transplant Proc; 1992 Oct; 24(5):1843. PubMed ID: 1412875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
